Skip to main content

Table 2 Intra-operative data

From: Sufentanil sublingual tablet system for enhanced recovery after total knee arthroplasty: a prospective observational case study

 

IV-morphine group (n = 15)

SL-sufentanil group (n = 15)

p

Surgical data

 Operated side

3 (20%)

7 (46%)

0.24

 Use of a tourniquet

12 (80%)

14 (93%)

0.59

 Surgical infiltration

14 (93%)

14 (93%)

1

 Ropivacain dose for infiltration (mg)

235 [200–300]

245 [200–300]

0.98

 Duration of surgery (min)

90 [83–106]

107 [88–122]

0.11

Anesthetic data

 General anesthesia

14 (93%)

12 (80%)

0.59

 Use of IV sufentanil (vs remifentanil)

11 (73%)

12 (80%)

1

 Total IV sufentanil dose (μg)

35 [30–50]

37.5 [31.3–47.5]

0.72

Spinal anesthesia

1 (6%)

3 (20%)

0.59

 Intrathecal bupivacain dose (mg)

15 [15–15]

15 [12.5–15]

-

 Intrathecal sufentanil dose (μg)

5 [5–5]

5 [5–5]

-

Adductor canal block

14 (93%)

14 (93%)

1

 Ropivacain dose used for block (mg)

40 [20–95]

40 [37.5–90]

0.79

Others analgesics

 IV dexamethasone

14 (93%)

9 (60%)

0.08

 Dexamethasone dose (mg)

2 [0–5]

2 [0–4]

0.65

 IV ketamine

12 (80%)

7 (47%)

0.13

 Total ketamine dose (mg)

20 [15–23.7]

20 [15–25]

0.69

 IV paracetamol

15 (100%)

14 (93%)

1

 Paracetamol dose (g)

1 [1–1]

1 [1–1]

1

 IV ketoprofene

12 (80%)

8 (53%)

0.25

 Ketoprofene dose (mg)

100 [100–100]

100 [100–100]

0.26

 IV nefopam

8 (53%)

9 (60%)

1

 Nefopam dose (mg)

20 [20–20]

20 [20–20]

1

  1. Values are medians [interquartiles 25–75%] or numbers (%)
  2. IV intravenous